Samsara BioCapital, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001744967 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Nov 14, 2019

Total Value: $147M (100.0% shares, 0.0% debt)

Holdings (18)

— Intercept Pharmaceuticals Inc 18.2%

Value $26.79M Shares 403,688 Est. Cost $88.27 Unrealized —

— Allakos Inc 15.4%

Value $22.58M Shares 287,205 Est. Cost $52.27 Unrealized —

— Syros Pharmaceuticals Inc 11.6%

Value $17.01M Shares 1,726,603 Est. Cost $6.82 Unrealized —

— Springworks Therapeutics Inc 10.0%

Value $14.67M Shares 676,602 Est. Cost $21.68 Unrealized —

— Odonate Therapeutics Inc 9.3%

Value $13.6M Shares 522,637 Est. Cost $14.81 Unrealized —

— Principia Biopharma Inc 7.4%

Value $10.83M Shares 383,480 Est. Cost $27.39 Unrealized —

— Sutro BioPharma Inc 7.0%

Value $10.23M Shares 1,125,579 Est. Cost $9.02 Unrealized —

— Atreca Inc 4.9%

Value $7.238M Shares 591,368 Est. Cost $18.84 Unrealized —

GOSS Gossamer Bio Inc 4.3%

Value $6.323M Shares 376,583 Est. Cost $20.85 Unrealized -4.6%

— Hookipa Pharma Inc 2.7%

Value $3.977M Shares 530,245 Est. Cost $6.73 Unrealized —

— Aravive Inc 2.3%

Value $3.32M Shares 442,733 Est. Cost $3.52 Unrealized —

— Sunesis Pharmaceuticals Inc 1.8%

Value $2.599M Shares 3,610,913 Est. Cost $1.01 Unrealized —

— Catabasis Pharmaceuticals Inc 1.1%

Value $1.62M Shares 300,000 Est. Cost $4.37 Unrealized —

UROV Urovant Sciences Ltd 1.0%

Value $1.491M Shares 157,480 Est. Cost $6.59 Unrealized —

— Evelo Biosciences Inc 0.9%

Value $1.388M Shares 227,529 Est. Cost $13.01 Unrealized —

KALV KalVista Pharmaceuticals Inc 0.9%

Value $1.375M Shares 118,500 Est. Cost $20.10 Unrealized -19.6%

— Millendo Therapeutics Inc 0.9%

Value $1.326M Shares 186,540 Est. Cost $7.31 Unrealized —

LQDA Liquidia Technologies Inc 0.4%

Value $550K Shares 154,462 Est. Cost $20.06 Unrealized -70.5%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Intercept Pharmaceuticals Inc	403,688	$26.79M	18.2%	$88.27	—	COM	45845P108
—	Allakos Inc	287,205	$22.58M	15.4%	$52.27	—	COM	01671P100
—	Syros Pharmaceuticals Inc	1,726,603	$17.01M	11.6%	$6.82	—	COM	87184Q107
—	Springworks Therapeutics Inc	676,602	$14.67M	10.0%	$21.68	—	COM	85205L107
—	Odonate Therapeutics Inc	522,637	$13.6M	9.3%	$14.81	—	COM	676079106
—	Principia Biopharma Inc	383,480	$10.83M	7.4%	$27.39	—	COM	74257L108
—	Sutro BioPharma Inc	1,125,579	$10.23M	7.0%	$9.02	—	COM	869367102
—	Atreca Inc	591,368	$7.238M	4.9%	$18.84	—	COM	04965G109
GOSS	Gossamer Bio Inc	376,583	$6.323M	4.3%	$20.85	-4.6%	COM	38341P102
—	Hookipa Pharma Inc	530,245	$3.977M	2.7%	$6.73	—	COM	43906K100
—	Aravive Inc	442,733	$3.32M	2.3%	$3.52	—	COM	03890D108
—	Sunesis Pharmaceuticals Inc	3,610,913	$2.599M	1.8%	$1.01	—	COM	867328700
—	Catabasis Pharmaceuticals Inc	300,000	$1.62M	1.1%	$4.37	—	COM	14875P206
UROV	Urovant Sciences Ltd	157,480	$1.491M	1.0%	$6.59	—	COM	G9381B108
—	Evelo Biosciences Inc	227,529	$1.388M	0.9%	$13.01	—	COM	299734103
KALV	KalVista Pharmaceuticals Inc	118,500	$1.375M	0.9%	$20.10	-19.6%	COM	483497103
—	Millendo Therapeutics Inc	186,540	$1.326M	0.9%	$7.31	—	COM	60040X103
LQDA	Liquidia Technologies Inc	154,462	$550K	0.4%	$20.06	-70.5%	COM	53635D202